Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmadi N, Brewer CC, Zalewski C, et al. Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations. Otolaryngol Head Neck Surg. 2011;145(2):295–302.
Akpolat T, Özkaya O, Özen S. Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients. Gene. 2012;492(1):285–9.
Aksentijevich I, Schnappauf O. Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases. Nat Rev Rheumatol. 2021;17(7):405–25.
Aksentijevich I, Zhou Q. NF-κB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases. Front Immunol. 2017;8:39. PMID: 28469620.
Aldea A. Am J Med Genet. 2004.
Alehashemi S, Goldbach-Mansky R. Human autoinflammatory diseases mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome dysregulation updates on diagnosis, treatment, and the respective roles of IL-1 and IL-18. Front Immunol. 2020;11:1840.
Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol Rheumatol. 2017;36:1707–13.
Almeida MQ, Tsang KM, Cheadle C, et al. Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: a link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors. Hum Mol Genet. 2011;20(1):165–75.
Alsarah A, Alsara O, Laird-Fick HS. Cardiac manifestations of familial Mediterranean fever. Avicenna J Med. 2017;7(4):158–63.
Ammouri W, Cuisset L, Rouaghe S, et al. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper-IgD syndrome. Rheumatology (Oxford). 2007;46(10):1597–600.
Andronikou S, Kraft JK, Offiah AC, et al. Whole-body MRI in the diagnosis of pediatric CNO/CRMO. Rheumatology (Oxford). 2020;59(10):2671–80.
Arostegui JI, Solis P, Aldea A, et al. Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response. Eur J Pediatr. 2005;164(1):13–6.
Arostegui JI, Anton J, Calvo I, et al. Open-Label, Phase II Study to assess the efficacy and safety of canakinumab treatment in active hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheumatol. 2017;69(8):1679–88.
Atoyan S, Hayrapetyan H, Sarkisian T, et al. MEFV and SAA1 genotype associations with clinical features of familial Mediterranean fever and amyloidosis in Armenia. Clin Exp Rheumatol. 2016;34(6):72–6.
Audu GK, Nikaki K, Crespi D, et al. Chronic recurrent multifocal osteomyelitis and inflammatory bowel diseases. J Pediatr Gastroenterol Nutr. 2015;60:586–91.
Badran YR, Dedeoglu F, Leyva Castillo JM, et al. Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. J Exp Med. 2017;214(7):1937–47.
Balci B, Tinaztepe K, Yilmaz E, et al. MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study. Nephrol Dialys Transpl. 2002;17(11):1921–3.
Balcı-Peynircioğlu B, Kaya-Akça U, Serap-Arıcı Z, et al. Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology (Oxford). 2020;59(6):1372–80.
Beck DB, Ferrada MA, Sikora KA, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383(27):2628–38.
Ben-Chetrit E. Familial Mediterranean fever (FMF) and renal AA amyloidosis--phenotype-genotype correlation, treatment, and prognosis. J Nephrol. 2003;16(3):431–4.
Ben-Chetrit E, Peleg H, Aamar S, Heyman S. The spectrum of MEFV clinical presentations – is it FMF only? Rheumatology. 2009;48:1455–9.
Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E. Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified? Arthritis Care Res. 2010;62:143–8.
Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E. Pregnancy outcomes in Ben-Chetrit E, Yazici H familial Mediterranean fever: different faces around the world. Clin Exp Rheumatol. 2019;37(Suppl. 121):S18–22.
Ben-Zvi I, Krichely-Vachdi T, Feld O, Lidar M, Kivity S, Livneh A. Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control. Orphanet J Rare Dis. 2014;9:3.
Booshehri LM, Hoffman HM. CAPS and NLRP3. J Clin Immunol. 2019;39:277–86.
Bourbon E, Heiblig M, Gerfaud Valentin M, et al. Therapeutic options in VEXAS syndrome: insights from a retrospective series. Blood. 2021;137(26):3682–4.
Boursier G, Rittore C, Milhavet F, et al. Mevalonate kinase-associated diseases: hunting for phenotype-genotype correlation. J Clin Med. 2021a;10(8):1552.
Boursier G, Piram M, Rittore C, et al. Phenotypic associations of PSTPIP1 sequence variants in PSTPIP1-associated autoinflammatory diseases. J Invest Dermatol. 2021b;141(5):1141–7.
Brik R, Litmanovitz D, Berkowitz D, et al. Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain. J Pediatr. 2001;138:759–62.
Cantarini L, Rigante D, Merlini G, Vitale A, Caso F, Lucherini OM, Sfriso P, Frediani B, Punzi L, Galeazzi M, Cimaz R, Obici L. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up. Semin Arthritis Rheum. 2014;43(6):818–2. PMID: 24393624.
Celkan T, Celik M, Kasapçopur O, et al. The anemia of familial Mediterranean fever disease. Pediatr Hematol Oncol. 2005;22(8):657–65.
Chavan P, Aksentijevich I, Daftary A, et al. Majeed syndrome-five cases with novel mutations from unrelated families in India with a review of literature. J Rheumatol. 2021;48(12):1850–5.
Chen Y, Ye Z, Chen L, et al. Association of clinical phenotypes in haploinsufficiency A20 (HA20) with disrupted domains of A20. Front Immunol. 2020;11:574992.
Chrcanovic BR, Guimaraes LM, Gomes CC, et al. Cherubism: a systemic literature review of clinical and molecular aspects. Int J Oral Maxillofac Surg. 2021;50(1):43–50.
Cox AJ, Ferguson PJ. Update on the genetics of nonbacterial osteomyelitis in humans. Curr Opin Rheumatol. 2018;30:521–5.
Cox AJ, Darbro BW, Laxer RM, et al. Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO). PLoS One. 2017;12(3):e0169687.
Cudrici C, Deuitch N, Aksentijevich I. Revisiting TNF receptor-associated periodic syndrome (TRAPS): current perspectives. Int J Mol Sci. 2020;21(9):3263.
D’Osualdo A, Ferlito F, Prigione I, et al. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis - pathogenetic and clinical implications. Arthritis Rheum. 2006;54(3):998–1008.
De Benedetti F, Gattorno M, Anton J, et al. Canakinumab for the treatment of autoinflammatory recurrent fever syndromes. N Engl J Med. 2018a;378:1908–19.
De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, et al. Canakinumab for the treatment of autoinflammatory recurrent fever syndromes “cluster study” N. Engl J Med. 2018b;378:1908–19.
Delaleu J, Deshayes S, Rodrigues F, et al. Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS) related AA amyloidosis: a national case series and systematic review. Rheumatol (Oxford). 2021;60(12):5775–84.
Deshayes S, Georgine-Lavialle S, Hot A, et al. Efficacy of continuous interleukin 1 blockade in mevalonate kinase deficiency: a multicenter retrospective study in 13 adult patients and literature review. J Rheumatol. 2018;45(3):425–9.
Diav-Citrin O, Shechtman S, Schwartz V, Avgil-Tsadok M, Finkel-Pekarsky V, El-Shanti H, Majeed HA, El-Khateeb M. Familial mediterranean fever in Arabs. Lancet. 2006;367:1016–24.
Duncan CJA, Dinnigan E, Theobald R, et al. Early onset autoimmune diseases due to a heterozygous loss-of -function mutation in TNFAIP3 (A20). Ann Rheum Dis. 2017;77(5):783–6.
El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs. Lancet. 2006;367:1016–24.
Fradkin A, Yahav J, Zemer D, et al. Colchicine-induced lactose malabsorption in patients with familial Mediterranean fever. Isr J Med Sci. 1995;31(10):616–20.
Galon J, Aksentijevich I, McDermott MF, et al. TNFRSF1 mutations and autoinflammatory syndromes. Curr Opin Immunol. 2000;12(4):479–86.
Gattorno M, Pelagatti MA, Meini A, et al. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2008a;58(5):1516–20.
Gattorno M, Sormani MP, D’Osualdo A, et al. A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum. 2008b;58(6):1823–32.
Gattorno M, Obici L, Cattalini M, et al. Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study. Ann Rheum Dis. 2017;76(1):173–8.
Gattorno M, Hofer M, Federici S, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019;78(8):1025–32. https://doi.org/10.1136/annrheumdis-2019-215048.
Gemici AI, Sevindik OG, Akar S, Tunca M. Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine. Clin Exp Rheumatol. 2013;31(3 Suppl 77):57–9.
Giardino S, Lanino E, Morreale G, et al. Long-term outcome of a successful cord blood stem cell transplant in mevalonate kinase deficiency. Pediatrics. 2015;135(1):e211–5.
Goldbach-Mansky R, Dailey NJ, Canna SW, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med. 2006;355(6):581–92.
Govindaraj GM, Jain A, Peethambaran G, et al. Spectrum of clinical features and genetic variants in mevalonate kinase (MVK) gene of South Indian families suffering from Hyperimmunoglobulin D Syndrome. PLoS One. 2020;15(8):e0237999.
Grossman C, Kassel Y, Livneh A, et al. Familial Mediterranean fever phenotype in patients homozygous to the MEFV M694V mutation. Eur J Med Genet. 2019;62(6):103532.
Gusdorf L, Lipsker D. Neutrophilic urticarial dermatosis: an entity bridging monogenic and polygenic autoinflammatory disorders, and beyond. J Eur Acad Dermatol Venereol. 2020;34(4):685–90.
Haimov-Kochman R, Ben-Chetrit E. The effect of colchicine treatment on sperm production and function - a review. Hum Reprod. 1998;13:360–2.
Hentgen V, Grateau G, Stankovic-Stojanovic K, Amselem S, Jéru I. Familial Mediterranean fever in heterozygotes: are we able to accurately diagnose the disease in very young children? Arthritis Rheum. 2013;65(6):1654–62.
Hochstadter EF, Ben-Shoshan M. Cold-induced urticaria: challenges in diagnosis and management. BMJ Case Rep. 2013;2013:bcr2103010441.
Holzinger D, et al. Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases. J Allergy Clin Imunol. 2015;1(36):337–1345.
Honda Y, Maeda Y, Izawa K, et al. Rapid flow cytometry-based assay for the functional classification of MEFV variants. J Clin Immunol. 2021;41(6):1187–97.
Houx L, Hachulla E, Kone-Paut I, et al. Musculoskeletal symptoms in patients with cryopyrin-associated periodic syndromes: a large database study. Arthritis Rheumatol. 2015;67(11):3027–36.
Indraratna PL, Virk S, Gurram D, et al. Use of colchicine in pregnancy: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(2):382–7.
Jacobelli S, Andre M, Alexandra JF, et al. Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). Rheumatology (Oxford). 2007;46(7):1211–2.
Jéru I, Hentgen V, Cochet E, et al. The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach. PLoS One. 2013;8(7):e68431.
Jeyaratnam J, Frenkel J. Management of mevalonate kinase deficiency: a pediatric perspective. Front Immunol. 2020;11:1150.
Kadowaki T, Ohnishi H, Kawamato N, et al. Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders. J Allergy Clin Immunol. 2018;141:1485–8.
Kallinich T, Haffner D, Rudolph B, et al. “Periodic fever” without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis. Ann Rheum Dis. 2006;65(7):958–60.
Kallinich T, Haffner D, Niehues T, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007;119(2):e474–83.
Karacan İ, Uğurlu S, Tolun A, Tahir Turanlı E, Ozdogan H. Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF. Clin Exp Rheumatol. 2017;35 Suppl 108(6):75–81.
Korkmaz C, Özdogan H, Kasapçopur Ö, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis. 2002;61:79–8.
Kuemmerle-Deschner JB, Ramos E, Blank N, et al. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS). Arthritis Res Ther. 2011;13(1):R34.
Kuemmerle-Deschner JB, Hofer F, Endres T, et al. Real-lifer effectiveness of canakinumab in cryopyrin-associated periodic syndromes. Rheumatology (Oxford). 2016;55(4):689–96.
Kuemmerle-Deschner JB, Ozen S, Tyrrell PN. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS). Ann Rheum Dis. 2017;76(6):942–7.
Kukuy O, Livneh A, Ben-David A, et al. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients. J Rheumatol. 2013;40(12):2083–7. https://doi.org/10.3899/jrheum.130520. Epub 2013 Oct 15.
Lachmann HJ, Sengul B, Yavuzsen TU, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746–50.
Lidar M, Kedem R, Mor A, et al. Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol. 2005;32(5):859–62.
Lytle A, Bagg A. VEXAS; a vivid new syndrome associated with vacuoles in various hematopoietic cells. Blood. 2021;137(26):3690.
Marchado RA, Pontes HAR, Pires HM, et al. Clinical and genetic analysis of patients with cherubism. Oral Dis. 2017;23(8):1109–15.
Marzano AV, Damiani G, Ceccherini I, et al. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol. 2017;176:1588–98.
Masters SL, Lagou V, Jeru I, et al. Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. Sci Transl Med. 2016;8:332ra45.
McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97(1):133–44.
Medlej-Hashim M, Delague V, Nabiha Salem E, et al. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med Genet. 2004;5:4.
Migita K, Izumi Y, Jiuchi Y, et al. Familial Mediterranean fever is no longer a rare disease in Japan. Arthritis Res Ther. 2016;30(18):175.
Mimouni A, Magal N, Stoffman N, et al. Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics. 2000;105(5):E70.
Mistry P, Carmona-Rivera C, Ombrello AK, et al. Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome. Ann Rheum Dis. 2018;77(12):1825–33.
Morbach H, Hedrich CM, Beer M, et al. Autoinflammatory bone disorders. Clin Imunol. 2013;147(3):185–96.
Nakanishi H, Kawashima Y, Kurima K, et al. NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy. Proc Natl Acad Sci U S A. 2017;114(37):e7766–75.
Nakanishi H, Prakash P, Ito T, et al. Genetic hearing loss associated with autoinflammation. Front Neurol. 2020;11:41.
Neven B, Valayannopoulos V, Quartier P, et al. Allogeneic bone marrow transplantation in mevalonic aciduria. NEJM. 2007;356(26):2700–3.
Obici L, Merlini G. Amyloidosis in autoinflammatory syndromes. Autoimmun Rev. 2012;12(1):14–7.
Omenetti A, Carta S, Caorsi R, et al. Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome. Rheumatology (Oxford). 2016;55:1325–35.
Ozen S, Kone-Paut I, Gul A. Colchicine resistance and intolerance in familial Mediterranean fever: definition, causes, and alternative treatments. Semin Arthritis Rheum. 2017;47(1):115–20.
Özen S, Sag E, Ben-Chetrit E, et al. Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a Delphi consensus approach. Rheumatology (Oxford). 2020;60(8):3799–808. https://doi.org/10.1093/rheumatology/keaa863.
Ozkan Y, Varol A, Turker N, et al. Clinical and radiological evaluation of cherubism: a sporadic case report and review of the literature. Int J Pediatr Otorhinolaryngol. 2003;67(9):1005–12.
Park YH, Remmers EF, Lee W, et al. Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis. Nat Immunol. 2020;21:857–67.
Pelagatti MA, Meini A, Caorsi R, et al. Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Arthritis Rheumatol. 2011;63(4):1151–0.
Peleg H, Ben-Chetrit E. The kidney in FMF. J Rheumatol. 2013;40(12):1948–50. https://doi.org/10.1186/1471-2350-5-4.
Pham M, Ressler S, Rosenthal A, et al. Classical Hodgkin lymphoma masquerading as chronic recurrent multifocal osteomyelitis: a case report. J Med Case Rep. 2017;11(1):45.
Rowczenio DM, Iancu DS, Trojer H, et al. Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue-a case series and genetic exploration. Rheumatology (Oxford). 2017a;56(2):209–13.
Rowczenio DM, Gomes SM, Arostegui JI, et al. Late-onset cryopyrin-associated periodic syndromes caused by somatic NLRP3 mosaicism-UK single center experience. Front Immunol. 2017b;80:1410.
Ruiz-Ortiz E, Iglesias E, Soriano A, et al. Disease phenotype and outcome depending on the age at disease onset in patients carrying the R92Q low-penetrance variant in TNFRSF1A gene. Front Immunol. 2017;8:299.
Sarı I, Birlik M, Kasifoğlu T. Familial Mediterranean fever: an updated review. Eur J Rheumatol. 2014;1(1):21–33. https://doi.org/10.5152/eurjrheum.2014.006. Epub 2014 Mar 1.
Sarkisian T, Ajrapetian H, Beglarian A, Shahsuvarian G, Egiazarian A. Familial Mediterranean fever in Armenian population. Georgian Med News. 2008;156:105–11.
Sato TS, Watal P, Ferguson PJ. Imaging mimics of. Chronic recurrent multifocal osteomyelitis; avoiding pitfalls in a diagnosis of exclusion. Pediatr Radiol. 2020;50(1):124–36.
Schnabel A, Range U, Hahn G, et al. Treatment response and outcomes in children with chronic nonbacterial osteomyelitis. J Rheumatol. 2017;44(7):1058–65.
Schnappauf O, Chae JJ, Kastner DL, et al. The pyrin inflammasome in health and diseases. Front Immunol. 2019;10:1745.
Sevoyan MK, Sarkisian TF, Beglaryan AA, Shahsuvaryan GR, Armenian HK. Prevention of amyloidosis in familial Mediterranean fever with colchicine: a case-control study in Armenia. Med Princ Pract. 2009;18(6):441–6. https://doi.org/10.1159/000235892.
Shimizu M, Tone T, Toga A, et al. Colchicine-responsive chronic recurrent multi focal osteomyelitis with MEFV mutations: a variant of familial Mediterranean fever? Rheumatology. 2010;49:2221–3.
Shinar Y, Ceccherini I, Rowczenio D, et al. ISSAID/EMQN best practice guidelines for the genetic diagnosis of monogenic autoinflammatory diseases in the next-generation sequencing era. Clin Chem. 2020;66:525–36.
Sibley CH, Plass N, Snow J, et al. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes. Arthritis Rheum. 2012;64(7):2375–86.
Sibley CH, Chioato A, Felix S, et al. A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease. Ann Rheum Dis. 2015;74(9):1714–9.
Sotskiy PO, Sotskaya OL, Hayrapetyan HS, et al. Infertility causes and pregnancy outcome in patients with familial Mediterranean fever (FMF) and controls. J Rheumatol. 2021;48:608–14.
Tanaka N, Izawa K, Saito MK, et al. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study. Arthritis Rheum. 2011;63:3625–32.
Tanaka T, Yoshioka K, Nishikomori R, et al. National survey of Japanese patients with mevalonate kinase deficiency reveals distinctive genetic and clinical characteristics. Mod Rheumatol. 2019;29(1):181–7.
Ter Haar NM, Jeyaratnam J, Lachmann HJ, et al. The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever registry. Arthritis Rheum. 2016;68(11):2795–805.
Terkeltaub TA, Furst DE, DiGiacinto JL, Kook KA, Davis MW. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibition. Arthritis Rheum. 2011;63:2226–37.
Tlougen BE, Podjasek JO, O’Haver J, et al. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature. Pediatr Dermatol. 2009;26(5):497–505.
Touitou I, Sarrabay G. Criteria for CAPS, is it all in the name? Ann Rheum Dis. 2017;76(5):e9.
Touitou I, Sarkisian T, Medlej-Hashim M, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007;56(5):1706–12.
Ueki Y, Lin CY, Senoo M, et al. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 “cherubism” mice. Cell. 2007;128:71–83.
van der Meer JW, Vossen JM, Radl J, et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet. 1984;1(8386):1087–90.
Van Gorp H, et al. Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever. Ann Rheum Dis. 2020;79:960–8.
Williamson LM, Hull D, Mehta R, et al. Familial Hibernian fever. Q J Med. 1982;51(204):469–80.
Zhang S. Natural history of mevalonate kinase deficiency: a literature review. Pediatr Rheumatol Online J. 2016;14(1):30.
Zhao DY, McCAnn L, Hahn G, et al. Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO). J Transl Autoimmun. 2021;4:100095.
Zhou Q, Wang H, Schwartz DM, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48:67–73.
Znajdek M, Gazda A, Gietka P, et al. Juvenile spondyloarthritis and chronic recurrent multifocal osteomyelitis overlap syndrome in a 16-year-old adolescent. A case report and literature review. J Ultrason. 2019;19(77):152–7.
Acknowledgments
We would like to thank Dr. Daniel Kastner for sharing his expertise and suggestions for the myths and pearls in the FMF section. We also thank Drs. Marco Gattorno, Alberto Martini, Raphaela Goldbach-Mansky, Pamela Aubert, and Polly J. Ferguson for their contributions to the first edition of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Aksentijevich, I., Ben-Chetrit, E. (2023). Monogenic Autoinflammatory Syndromes. In: Stone, J.H. (eds) A Clinician's Pearls & Myths in Rheumatology. Springer, Cham. https://doi.org/10.1007/978-3-031-23488-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-031-23488-0_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-23487-3
Online ISBN: 978-3-031-23488-0
eBook Packages: MedicineMedicine (R0)